Zhenrui He

Title: Zhenrui He: Innovator in Fusion Protein Technology

Introduction

Zhenrui He is a notable inventor based in Shanxi, China. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has the potential to enhance immune responses against various pathogens.

Latest Patents

Zhenrui He holds a patent for a fusion protein and its applications. The patent describes a fusion protein that consists of a trimerization block and an immunogenic block connected by a linker. The trimerization block includes repeat units as specified in SEQ ID NO. 1. The immunogenic block is derived from a pathogen, such as a coronavirus RBD block, an HIV membrane protein, or an influenza virus hemagglutinin protein, along with their immunogenic fragments. This trimeric structure is designed to generate a higher neutralizing antibody level compared to a monomeric immunogen. It also minimizes the induction of strong antibodies against the trimerization block in the human body, thereby promoting a more focused immune response.

Career Highlights

Zhenrui He has worked with Shanxi Jinbo Bio-pharmaceutical Co., Ltd. and Fudan University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Lu Lu and Shibo Jiang. Their collaborative efforts have further advanced the research and development of innovative biotechnological solutions.

Conclusion

Zhenrui He is a prominent figure in the field of fusion protein technology, with a patent that showcases his innovative approach to enhancing immune responses. His work continues to influence the biotechnology landscape, paving the way for future advancements.